INTRODUCTION
============

Throughout their life cycle, small non-coding RNAs (sRNAs) that function as regulators of gene expression may interact with a variety of proteins. These include proteins that govern the maturation, turnover or intracellular transport of sRNAs; target proteins whose *in vivo* functions are modulated by an sRNA; and the auxiliary factors that help sRNAs recognize non-protein targets such as RNA, DNA or small metabolites. Over the years, various strategies have been used to isolate proteins along with RNA by means of RNA-based affinity chromatographic methods. The most direct approach is the immobilization of the RNA of interest on a column to which then cellular protein fractions are applied. For immobilization, *in vitro*-synthesized unmodified bait RNA is covalently coupled to cyanogen bromide (CNBr)-activated sepharose ([@B1]). Alternatively, modification of an *in vitro-*synthesized RNA can be used to facilitate its covalent or non-covalent attachment to the solid phase ([@B2; @B3; @B4; @B5]). Collectively, these methods rely upon RNA--protein interaction to take place after cellular lysate preparation, and therefore do not allow the isolation of *in vivo* assembled RNA--protein complexes.

To identify RNA-associated proteins, it remains desirable to purify a given RNA from its native source. Therefore, other strategies were developed in which a highly specific and non-covalent interaction with the RNA moiety is used for selection of, for example, eukaryotic ribonucleoprotein particles (RNPs) under non-denaturating conditions. Initially, biotinylated antisense oligonucleotides complementary to accessible, single-stranded regions of the RNP-contained RNA were used as affinity baits ([@B6],[@B7]). More recently, the addition of diverse natural or *in vitro* selected RNA aptamer sequences to the RNA of interest has provided a convenient tool for RNP separation and purification; these aptamers bind their ligands with an affinity similar to that observed for natural antibodies. Aptamer tags specific for small molecules, e.g. streptavidin ([@B8]), streptomycin ([@B9],[@B10]), or tobramycin ([@B11]), or for proteins and peptides, e.g. MS2 coat protein ([@B12; @B13; @B14]) and λ~N22~ peptide ([@B15],[@B16]), were successfully used for the isolation of a variety of RNPs. Recently, two RNA aptamers, one specific for the *Pseudomonas* phage 7 coat protein and the other for tobramycin, were used in combination for RNP purification ([@B17]).

Bacteria are known to express many regulatory sRNAs with diverse physiological functions ([@B18; @B19; @B20; @B21; @B22; @B23]). These sRNAs are typically 50--250 nucleotides in length, differ in structure from each other, and are generally untranslated. Depending on their mode of action, some bacterial sRNAs directly target proteins, e.g. 6S RNA which binds to and modifies the sigma factor affinity of RNA polymerase ([@B24]), or the family of CsrB-like RNAs which antagonizes CsrA/RsmA-like regulatory proteins ([@B25],[@B26]).

The major class of regulatory sRNAs in bacteria targets *trans*-encoded mRNAs by antisense pairing ([@B27]). Target pairing is generally short and imperfect, and most often requires the bacterial Sm-like protein, Hfq, for successful target interaction ([@B28],[@B29]). Recent co-immunoprecipitation experiments showed that up to half of all known *Escherichia coli* or *Salmonella* sRNAs may bind Hfq *in vivo* ([@B30; @B31; @B32]). However, we generally know little about the nature and number of proteins bacterial sRNAs associate with throughout their life time as regulators ([@B33]).

In this work, we have studied whether aptamer-tagging can be used to recover *in vivo* expressed regulatory sRNAs of *Salmonella* along with the commonly associated Hfq protein. We selected for study three structurally unrelated *Salmonella* sRNAs, i.e. GcvB, InvR and RybB ([Figure 1](#F1){ref-type="fig"}A). Collectively, these sRNAs repress *trans*-encoded target mRNAs by Hfq-dependent base-pairing mechanisms. GcvB is a widely conserved 200 nt RNA which was originally identified in *E. coli* ([@B34]) and recently shown to directly target many *Salmonella* ABC transporter mRNAs ([@B35]); one of its targets is the *oppA* mRNA encoding a function in the major oligopeptide transport system. InvR (80 nt) RNA is expressed from the *Salmonella*-specific invasion gene island, and targets *ompD* mRNA encoding the major outer membrane protein of *Salmonella* under conditions of eukaryotic host cell invasion ([@B36]). The 80 nt RybB RNA also down-regulates outer membrane protein (OMP) synthesis yet in a rather global fashion; when overproduction of OMPs causes envelope instability, RybB expression is activated by the specialized sigma factor, σ^E^, and the sRNA then promotes the rapid decay of all major and many minor *omp* mRNAs of *Salmonella* to restore envelope homeostasis ([@B37]). Figure 1.Regulatory sRNAs. Sequences of (**A**) the *Salmonella* RybB, InvR and GcvB sRNAs, and (**B**) the various aptamer tags specific for phage MS2 coat protein (MS2 and MS2\*), for λN~22~ peptide (1xboxB and 4xboxB), or the eukaryotic initiation factor 4A (eIF4A) used in the present study. Shadowed nucleotides denote residues of the three *Salmonella* sRNAs that are involved in base-pairing to target mRNAs.

We have tested how the addition of any of three well-investigated aptamer sequences (MS2, boxB, eIF4A; [Figure 1](#F1){ref-type="fig"}B) impacts on the expression levels and regulatory properties of sRNAs, and have successfully used MS2 aptamer-tagged GcvB, InvR or RybB RNAs for Hfq co-purification from *Salmonella* extracts. We provide an optimized protocol for affinity purification of MS2 aptamer-tagged sRNAs that may facilitate the isolation of *in vivo* assembled sRNA--protein complexes in a wide range of bacteria. Our protocol further proves useful for the subsequent proteome analysis of the purified complexes by mass spectrometry.

MATERIALS AND METHODS
=====================

Plasmid construction
--------------------

DNA oligonucleotides and plasmids used in this study are listed in [Supplementary Tables S1 and S2](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1). In the following, a detailed description of the construction of GcvB aptamer expression plasmids and the control plasmids is given. The details of the RybB/InvR expression plasmids are found in the [Supplementary Text and Table S2](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1).

For GcvB plasmids pNS-7 and pNS-8, plasmid pTP005 was amplified with primer pairs JVO-2660/-2661 (introduce MS2 tag), and JVO-2658/-2659 (introduce eIF4A tag) and the PCR product was re-ligated.

To construct the general vectors, two complementary oligodesoxynucleotides, JVO-2750 and JVO-2751 containing the 1xboxB aptamer flanked by *Nhe*I and *Xba*I cleavage sites and the *vrrA* sequence flanked by the *Avr*II restriction site, were annealed and digested with *Avr*II. The DNA fragment was inserted by blunt-end/*Avr*II*-Xba*I cloning into plasmid vector pJV752. The resulting plasmid, pNS-18, which now harbored the 1xboxB aptamer cassette, subsequently served as the parental plasmid for construction of additional general aptamer plasmids that carry 4xboxB (pNS-20), eIF4A (pNS-19) or MS2\* (pNS-21) cassettes. To this end, the 1xboxB cassette was excised from pNS-18 by *Nhe*I/*Xba*I digest, and replaced with *Nhe*I/*Xba*I treated DNA fragment with the new aptamer sequence. Inserts were obtained by PCR with primer JVO-2754/2755 for eIF4A, or JVO-2756/-2757 for MS2\*, and using plasmids pNS-3 or pMS2\* respectively, as PCR templates. The 4xboxB aptamer fragment was obtained by annealing complementary oligodesoxynucleotides JVO-2752 and JVO-2753.

To construct plasmids in which GcvB sRNA is 3′-end-tagged with an aptamer, the *gcvB* gene of plasmid pTP005 was amplified with primer pair pZE-A/JVO-2956, which yielded the sRNA gene but without the native *gcvB* terminator, and with a *Nhe*I restriction site at the 3′ of the gene fragment. These fragments were digested with *Xho*I and *Nhe*I, and inserted into the aforementioned general aptamer vectors (pNS-18, pNS-19, pNS-20 or pNS-21) (note that *Xho*I cloning remove the plasmid-borne P~LlacO-1~ promoter, thus the sRNA fragment must contain the native sRNA promoter). This gave yield to plasmids pNS-22, pNS-27, pNS-31 and pNS-32.

Control vector, pNS-17, was generated by *Nhe*I/*Xba*I digest of plasmid pNS-18, followed by re-ligation of the vector backbone. This control plasmid expresses a ∼80 nt nonsense RNA that corresponds to the *rrnB* terminator of the plasmid and vector sequences upstream of the terminator.

To construct the MS2 control plasmid pRR-05, which expresses a short MS2 tag RNA, plasmid pNS-10 was amplified with primer pair JVO-1745/-3446, and religated.

All plasmids used throughout this study were introduced into *Salmonella* by electroporation as described ([@B38]).

Bacterial strains and growth conditions
---------------------------------------

*Salmonella* strain JVS-2999, which is a non-infectious *aroA* mutant of *Salmonella enterica* serovar Typhimurium, is referred to as the *Salmonella* wild-type strain throughout this study. It corresponds to *S. typhimurium* SL7207 strain (2337--65 (WRAY) *hisG*46Δ*aroA*407 (Tc^s^*aroA*544::Tn10) as published ([@B39]), and was kindly provided by the Department of Immunology at the MPI for Infection Biology, Berlin, Germany. For experiments in [Figure 7](#F7){ref-type="fig"}B, the virulent *Salmonella* strain SL1344 (JVS-0007) was used. Figure 2.Cloning strategies for plasmids to express aptamer-tagged sRNAs. (**A**) Strategy I: an aptamer tag is introduced by addition of the sequence to PCR primers and amplification of a plasmid that carries the sRNA gene of interest. This strategy permits the insertion of the aptamer at any position in the sRNA sequence. (**B**) Strategy II: alternatively, sRNA fragments are amplified by PCR and introduced into the general aptamer cloning vectors, pNS-18, pNS-19, pNS-20 and pNS-21, using unique *Nhe*I and *Xba*I sites. This strategy permits to fuse the aptamer to either the 5′-end (insertion at *Xba*I site) or 3′-end (*Nhe*I) of the sRNA. Cloned fragment will be expressed from a P~LlacO-1~ promoter located immediately upstream of the *Nhe*I site. Alternatively, cloning in the *Xho*I--*Nhe*I region permits expression of an sRNA from its own promoter. Figure 3.Expression and target regulation of aptamer-tagged sRNAs*.* (**A**) Northern and western blot analyses of *Salmonella* Δ*gcvB* (strain JVS-3143) carrying an 'empty' control vector (lane 1, pNS-17), or plasmids expressing wild-type (lane 2, pTP005) or aptamer-tagged GcvB sRNAs (lanes 3--8). The schematic drawing to the left shows the sRNA sequences in black, aptamer sequence in red, and (where applicable) the *vrrA* transcription terminator sequence in green. Co-transcribed linker sequences unrelated to aptamer, sRNA or *vrrA* terminator sequences are shown in grey. The expected length (in nucleotides) of the expressed RNA is given. [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1) presents the sequence of the RNAs and connects the insert names to the expression plasmids. The top panel shows the relevant section of a northern blot probed with GcvB-specific oligonucleotide, JVO-0749. Asterisks indicate bands of expected full-length sRNAs. Positions of a co-migrating size marker are shown to the right of the blot. The middle panel shows probing for 5S rRNA to confirm equal loading. The bottom panel shows the relevant section of a western blot probed with a polyclonal serum against OppA protein, whose synthesis is repressed by GcvB sRNA. The OppA-specific band is indicated by an arrowhead. RNA and protein samples were prepared as described in 'Materials and Methods' section. (**B**) Analyses as above but of *Salmonella* Δ*invR* (JVS-3008) and InvR expression plasmids. Wild-type InvR sRNA was expressed from plasmid pNS-9, and the sRNAs were detected with oligonucleotide probe, JVO-0222 (top panel). The third panel from top shows the section of a western blot probed with a general anti-porin serum in order to detect down-regulation of OmpD synthesis by InvR sRNAs. Bottom panel: the same blot probed for GroEL protein as loading control. (**C**) Analyses of *Salmonella* Δ*rybB* (JVS-3142) and RybB plasmids (pNS-13 for expression of wild-type RybB). Detection of the sRNA (top panel) was done with oligonucleotide probe, JVO-2644. Regulatory activity of the sRNAs was evaluated by western blot probing of major porins (third panel from top) whose synthesis is negatively controlled by RybB. Figure 4.Experimental strategy to purify MS2 aptamer-tagged sRNAs and possibly *in vivo* formed RNPs under non-denaturing conditions from bacterial lysates. Red lines denote aptamer tags, yellow and green circles the MS2 coat protein and the maltose-binding protein (MPB) moieties of the MS2--MBP fusion protein that binds to the subunits of the amylose column (black circles). Figure 5.(**A**) Affinity purification of *in vivo* expressed MS2-tagged GcvB, InvR and RybB sRNAs**.** Shown are northern blot analyses of RNA prepared before, during or after the affinity purification described in the 'Materials and Methods' section. We analyzed *Salmonella* strains *hfq*^3×FLAG^Δ*sRNA or hfq*^3×FLAG^ harboring the RNA expression plasmids (from top to bottom: pNS-7 and pTP005 in strain JVS-3790, pNS-10 and pNS-9 in strain JVS-3618, pNS-14 and pNS-13 in strain JVS-3789 and pRR-05 in strain JVS-3616). RNA samples were prepared from intact cells before lysate preparation (lane 1), from the cleared lysate shortly before loading onto the column (lane 2), from the flow-through fraction collected after loading on a column pre-incubated with MS2-MBP protein (lane 3), from the combined column wash fractions (lane 4) and of the eluate (lane 5). Note that the amount of RNA loaded in lanes 1--4 each corresponds to 1 OD~600~ of bacterial culture, but in lane 5 the eluate corresponds to 10 OD~600~ of culture. Oligonucleotide probes to detect sRNAs were as in [Figure 3](#F3){ref-type="fig"}; the MS2 control RNA was detected using JVO-3562. Comparison of the sRNA signal in the eluates of a wild-type sRNA versus its MS2 variant proves the specific isolation of the aptamer-tagged sRNAs. (**B**) Co-purification of Hfq with MS2-tagged sRNAs. Protein fractions of the samples shown in (A) were analyzed on western blot using a monoclonal antibody directed against the FLAG-epitope tag of the Hfq^3×FLAG^ protein. Loaded protein samples correspond to 0.05 OD~600~ of bacterial culture for lanes 1--4 and to 10 OD~600~ for the eluate (lane 5). Enrichment of Hfq^3×FLAG^ in the eluate samples of MS2-tagged GcvB, InvR and RybB, but not of MS2 control RNA argues that the protein was bound to the sRNA rather than the MS2 sequence. Figure 6.Several proteins co-purify with MS2-tagged InvR sRNA. Proteins of the lysate, flow-through, wash (0.1 OD~600~) and eluate (50 OD~600~) fractions were separated on an SDS-gel and stained with silver. Positions of the eluted MS2-MBP, the endogenous MBP of Salmonella (marked by an asterisk) and the co-purified FLAG-tagged Hfq are indicated right to the gel. Lysis with French press and affinity chromatography were performed with buffer A containing either the standard concentration of 150 mM KCl, or 1 M KCl. The eluate fractions of the affinity chromatography using the increased KCl concentration were analysed by mass spectrometry. Positions of co-migrating size marker proteins (in kDa) are shown to the left. Figure 7.Analysis of chromosomally tagged RybB sRNA. (**A**) A PCR-product containing the MS2-tagged sRNA flanked by homologous regions (H1 and H2) to the sRNA locus is integrated into the bacterial chromosome via λRed-mediated recombination. The integrated sRNA is selected by the attached antibiotic resistance gene. (**B**) Northern blot analysis of chromosomally expressed RybB RNAs (under control of σE) and *ompN* target mRNA. Wild-type *Salmonella* (JVS-0007) and *Salmonella* with chromosomally MS2-tagged RybB (*rybB-*MS2, JVS-4892) carrying a control plasmid (pBAD) or an arabinose-inducible σE expression plasmid (pBAD--RpoE) were induced in early stationary phase. RNA was prepared prior to (0 min) and at 2, 5 and 10 min following induction, and probed as indicated. (**C**) Affinity purification. Prior to collection and lysis, *Salmonella* strains JVS-4279 and JVS-3617, both carrying the pBAD--RpoE expression plasmid, were grown to late exponential phase (OD~600~ of 1) and σE expression was induced for 5 min. Affinity purification and northern (RybB probe) and western (via the FLAG tag of Hfq) blot analyses were performed as in [Figure 5](#F5){ref-type="fig"} but loading eluate samples equivalent to 20 OD~600~ of bacterial culture.

The derivatives of JVS-2999 carrying sRNA deletions (JVS-3008, Δ*invR::*Km^R^; JVS-3142, Δ*rybB::*Km^R^; JVS-3143, Δ*gcvB::*Km^R^) and/or an epitope-tagged *hfq* gene (JVS-3618, *hfq*::3xFLAG Δ*invR::*Km^R^; JVS-3789, *hfq*::3xFLAG Δ*rybB::*Km^R^; JVS-3790, *hfq*::3xFLAG Δ*gcvB::*Km^R^) were constructed by phage P22 transduction of previously published strains as outlined in [Supplementary Table S3](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1).

To express endogenous RybB-MS2, we adapted the λRed recombinase method for one-step inactivation of chromosomal genes ([@B40]). The DNA fragment to be integrated (contains the aptamer-tagged sRNA of pNS-14 fused to the kanamycin resistance cassette of pKD4) was generated via overlapping PCR: the two DNA fragments obtained by PCR with primer pair JVO-906/3516 on pNS-14 and primer pair JVO-0203/3517 on pKD4 were mixed in equimolar amounts and used as template for a PCR with primer pairs JVO-3515/3521. The chromosomal RybB-MS2 mutation was subsequently transferred to strains JVS-0007 and JVS-3617, which results in JVS-4892 (used for functional studies in [Figure 7](#F7){ref-type="fig"}B) and JVS-4279 (used for affinity purification in [Figure 7](#F7){ref-type="fig"}C).

Bacterial strains were grown in LB (Lennox) broth at 37°C, 220 r.p.m., throughout this study. Antibiotics (where appropriate) were used at the following concentrations: 100 µg/ml ampicillin, 50 µg/ml kanamycin.

Sample preparation
------------------

Whole cell protein samples were prepared as follows: bacteria were cultured to an OD~600~ of 1 (for GcvB samples) or an OD~600~ of 2 (InvR, RybB) and samples equivalent to 0.5 OD~600~ (e.g. 0.5 ml of an OD~600~ of one culture) were removed and centrifuged for 2 min at 15 800*g* at 4°C. The pellet was suspended in 100 µl 1× protein loading buffer (Fermentas; \#R0891). Proteins were denatured for 5 min at 96°C, and separated by sodium dodecyl sulfate (SDS)--polyacrylamide gelelectrophoresis (PAGE) using 15% polyacrylamide gels.

For isolation of total RNA, samples equivalent to 2 OD~600~ were centrifuged as described earlier.

The pellet was dissolved in 1 ml TRIzol Reagent (Invitrogen), and RNA was isolated and precipitated as described ([@B38]). The precipitated RNA was directly dissolved in 20 µl loading buffer II (Ambion, \#AM8548G) and denatured for 3 min at 95°C. Ten microliters of each RNA sample were separated on 6% polyacrylamide/8.3 M urea gels.

To analyze chromosmal MS2-tagged RybB ([Figure 7](#F7){ref-type="fig"}B), bacteria were cultered to an OD~600~ of 1, at which sRNA expression was induced with [l]{.smallcaps}-arabinose for 10 min. Culture aliquots equivalent to 4 OD~600~ were removed, mixed with 0.2 volumes of stop solution (5% water-saturated phenol, 95% ethanol) and snap-frozen in liquid nitrogen. After thawing on ice, bacteria were pelleted and the RNA was isolated as described earlier. The purified RNA was quantified on a Nanodrop Machine (NanoDrop Technologies). RNA samples (∼6 µg) were denatured for 3 min at 95°C in loading buffer II and separated on 6% polyacrylamide/8.3 M urea gels.

Purification of MS2-MBP fusion protein
--------------------------------------

For use as an affinity tag, MS2 coat protein fused to maltose-binding protein (MS2-MBP) was expressed in *E. coli*. This fusion places the maltose binding protein N-terminal to MS2 coat protein which carries a double mutation that prevents oligomerization ([@B41]). The fusion protein was purified first over an amylose (NEB) column in 20 mM HEPES pH 7.9, 200 mM KCl, 1 mM EDTA, and then over a heparin column using a KCl gradient in the same buffer ([@B42]). Purity of the protein was evaluated by SDS--PAGE and Commassie brilliant blue staining.

Affinity purification
---------------------

The *Salmonella* strains indicated in figure legends were grown under standard laboratory conditions to an OD~600~ of 1 (GcvB) or 2 (InvR, RybB). Samples for the whole cell protein and the total RNA (culture samples) were prepared as described earlier. For affinity purification, cells equivalent to 50 OD~600~ were chilled on ice for 20 min and harvested (20 min, 2900*g*, 4°C). Cells were resuspended in 1 ml Buffer A (20 mM Tris--HCl pH 8.0, 150 mM KCl, 1 mM MgCl~2~, 1 mM DTT) and then cells were subsequently centrifuged (5 min, 11 200*g*, 4°C) and the pellets were shock-frozen in liquid nitrogen and stored at −80°C.

Frozen pellets were thawed on ice, resuspended in 2 ml Buffer A, followed by cell breakage using a French press (French Pressure Cell Press, SLM instruments). A pressure of 800 psi was applied to the cells for three times; the lysate was chilled on ice between every step. The lysate was cleared by centrifugation (30 min, 30 000*g*, 4°C) and the soluble fraction subjected to affinity chromatography.

All steps for affinity purification were performed at 4°C. For preparation of the affinity column, 50µl amylose resin (New England Biolabs, \#E8021S) was applied to Bio-Spin disposable chromatography columns (BioRad, \#732-6008). The prepared column was washed three times with 2 ml Buffer A. Next, 100 pmol MS2-MBP coat protein (diluted in 1 ml Buffer A) was immobilized on the amylose resin, and the column was washed with 2 ml of Buffer A (for the experiments in [Figure 6](#F6){ref-type="fig"}, 100 µl amylose resin and 1200 pmol MS2-MBP were used). Subsequently, the cleared bacterial lysate was loaded onto the column, followed by three washes with 2 ml Buffer A. For RNA analysis, aliquots equivalent to 2 OD~600~ of the lysate, the flow-through and the wash fractions were treated with 1 ml TRIzol reagent as described earlier. For protein analysis, aliquots equivalent to 0.5 OD~600~ were mixed with protein loading buffer to a final volume of 100 µl.

Finally, RNA and proteins were eluted from the column with 900 µl of Buffer A containing 12 mM maltose. Eluted RNA was extracted with phenol--chloroform--isoamylalcohol \[25 : 24 : 1 (v/v), Roth\], followed by ethanol (3 vol) precipitation of the aqueous phase in the presence of 20 µg yeast tRNA. Once re-dissolved in 25 µl water, the RNA was stored at −20°C. For protein isolation, the organic phase was subjected to acetone precipitation at −20°C over night. The pellet was washed twice with acetone and air-dried. The pellet was solved in 50 µl 1× protein loading buffer. For analysis of influence of different parameters on affinity purification changing conditions were used as indicated in the legend of [Figure 6](#F6){ref-type="fig"} and [Supplementary Figure S4](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1).

For the isolation of endogenous expressed RybB-MS2 ([Figure 7](#F7){ref-type="fig"}C), some parameters were modified. JVS-2999 and JVS-4279, both harboring pBAD-RpoE, were grown to an OD~600~ of 1 nm, at which sRNA expression was induced with [l]{.smallcaps}-arabinose for 5 min. Cells equivalent to 200 OD~600~ were chilled at −10°C for 5 min and harvested (20 min, 2900*g*, 4°C). The lysate was prepared as described above, cleared by centrifugation (15 min, 2900*g*, 4°C) and the soluble fraction was subjected to affinity chromatography in which 100 µl amylose resin and 300 pmol MS2-MBP coat protein were used.

Isolation of tagged sRNAs and co-purification of Hfq was performed in triplicates, and results were consistent. The results of representative experiments are shown.

Mass spectrometry
-----------------

For mass spectrometric analysis of InvR associated proteins, precipitated proteins were dissolved in 1× protein loading buffer and loaded onto a 4--12% NuPAGE-Gel (Invitrogen). After Coomassie stain gel lanes of affinity purified InvR-MS2 and InvR were cut into 23 slices and proteins therein are digested with Trypsin according to ([@B43]). Extracted peptides were analyzed by LC-MSMS on an Orbitrap XL instrument (ThermoFisherScientific) under standard conditions. Peptide fragment spectra were searched against a target-decoy database for *Salmonella typhimurium* strain LT2 (M. Selbach, personal communication) using MASCOT as search engine.

Northern blot analysis
----------------------

After polyacrylamide gel electrophoresis, the RNA was transferred to Hybond-XL membranes (GE Healthcare) by electro-blotting (1 h, 50 V, 4°C) in a tank electro blotter (Peqlab, \#52-WEB-20), and cross-linked to membrane by exposure to UV light (302 nm) for 4 min. The GcvB, InvR, RybB sRNA and the RNA with the MS2 tag alone were detected using γ-\[^32^P\] ATP 5′-end-labeled oligodeoxyribonucleotides JVO-0749 (antisense to nucleotides 4--20 of GcvB RNA), JVO-0222 (antisense to nucleotides 19--44 of InvR RNA), JVO-2644 (antisense to nucleotides 5--24 of RybB RNA), and JVO 3562 (antisense to nucleotides 8--31 of the MS2 aptamer), respectively. 5S rRNA (loading control) was detected with oligo JVO-0322; *ompN* mRNA was detected as described previously ([@B37]).

Prehybridization and hybridization of membranes with oligonucleotides was carried out each for 1 h in Roti-Hybri-Quick buffer (Roth) at 42°C. Following hybridization, membranes were rinsed in 5× SSC, followed by three washing steps at 42°C for 15 min in SSC (5×, 1× and 0.5×)/0.1% SDS solutions. Signals were visualized on a phosphorimager (Phosphorimager, FLA-3000 Series, Fuji), and band intensities quantified with AIDA software (Raytest, Germany).

Western blot analysis and silver staining
-----------------------------------------

For western blot analysis, polyvinylidene difluoride membrane (PVDF, PerkinElmer) was activated by incubation in methanol (90 s), H~2~O (5 min) and transfer buffer (5 min), respectively. After SDS--PAGE, the gel was blotted for 2 h at 2 mA/cm^2^ and 4°C in a semi-dry electro blotter (Peqlab, \#52--2020) onto the PVDF membrane in transfer buffer. After rinsing in TBST~20~, the membrane was incubated over night in 10% dry milk in TBTS~20~. OppA or Hfq^3×FLAG^ proteins, and the major OMPs, were detected using a polyclonal serum against OppA (1 : 3000 in TBST~20~-BSA), porin antiserum, which detects major porin such as OmpA/C/D/F (1 : 20000 in TBST~20~-BSA, provided by R. Misra) or a monoclonal anti-FLAG antibody (Sigma-Aldrich, \#F2555, 1 : 1000 in TBST~20~-BSA), for 1 h at room temperature under agitation. Membranes were washed 5×6 min in TBST~20~, incubated with either anti-mouse--horseradish peroxidase or anti-rabbit--horseradish peroxidase (GE Healthcare, 1:5000 in TBST~20~-BSA) for 1 h at room temperature and washed again 6×10 min in TBST~20~. Blots were analysed using Western Lightning Reagent (Perkin Elmer), and signals detected with a Fuji LAS-3000 CCD camera. Silver staining of the 15% polyacrylamide gel was performed according to ref. ([@B44]).

RESULTS
=======

Construction of plasmid-based aptamer-tagged sRNA genes
-------------------------------------------------------

To isolate *in vivo* expressed GcvB, InvR and RybB sRNAs from *Salmonella* by affinity chromatography, the sRNA genes were cloned on plasmids ([Figure 2](#F2){ref-type="fig"} and [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)) and modified with any of three RNA affinity tags ([Figure 1](#F1){ref-type="fig"}B). We used the following RNA affinity tags: (i) a tandem repeat of the 43 ([@B45]) or 50 nt ([@B46],[@B47]) variant of phage MS2 coat protein binding motif, to which we will refer as MS2 or MS2\*, respectively; (ii) monomeric (15 nt) or tetrameric (72 nt) versions of the λN~22~ peptide binding sequence ([@B16],[@B48]), here referred to as 1xboxB or 4xboxB, respectively; (iii) a 60 nt SELEX-derived aptamer sequence specific for the eukaryotic initiation factor 4A ([@B49]) which will be referred to as the eIF4A aptamer.

Based on prior knowledge of which region in the three sRNAs were required for target regulation, the aptamer sequences were introduced at various positions ([Figure 3](#F3){ref-type="fig"} and [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)). In GcvB RNA, the binding site for *oppA* mRNA is located between stem loops 1 and 2 \[[Figure 1](#F1){ref-type="fig"}A and ([@B35])\]; consequently, aptamer sequences were added to the 5′-end of GcvB (MS2 and eIF4A-a constructs), or replaced the *gcvB* transcription terminator (MS2\*, eIF4A-b, 1xboxB, 4xboxB). If an aptamer replaced the native transcription terminator, transcription was expected to terminate at a plasmid-borne terminator which derives from the *vrrA* sRNA gene of *Vibrio* species ([@B50]) and is located downstream of the sRNA cloning site. We used the heterologous *vrrA* terminator rather than a *Salmonella* or *E. coli* terminator to minimize possible recognition of the RNA 3′-end by *Salmonella* proteins. Concerning InvR, residues 33--66 of this RNA constitute the core interaction site for pairing with the *ompD* target mRNA \[([@B36]), and V. Pfeiffer and J. Vogel, unpublished data\]. Therefore, aptamers were either fused to the 5′-end of InvR (MS2, eIF4A-a), inserted upstream of the *invR* terminator (1xboxB-a), or cloned such that the aptamer replaced the *invR* terminator (MS2\*, eIF4A-b, 1xboxB-b, 4xboxB). The first 16 residues of RybB are stringently required for pairing to all *omp* target mRNAs ([@B51]); thus, aptamers were only cloned at positions downstream of RybB residue 31, by either insertion (MS2, 1xboxB) or terminator replacement (MS2\*, eIF4A, 4xboxB).

The pZ plasmid series ([@B52]) served as building blocks for construction of our aptamer-tagged sRNA expression plasmids; the p15A origin used here ensures 20--30 plasmid copies/cell. InvR and RybB sRNAs were expressed from a constitutive P~LlacO-1~ promotor ([@B52]) In contrast, GcvB was expressed from its native promotor since high expression of this sRNA is lethal in *Salmonella* ([@B35])*.*

We used two different cloning strategies ([Figure 2](#F2){ref-type="fig"}). The first strategy provides plasmids carrying the wild-type sRNA genes which were amplified using PCR primers that introduced the aptamer tag at the desired sRNA position ([Figure 2](#F2){ref-type="fig"}A). Second, we constructed general vectors harboring the 1xboxB (pNS-18), 4xboxB (pNS-20), eIF4A (pNS-19) or MS2\* (pNS-21) aptamer sequences flanked by unique *Nhe*I and *Xba*I cleavage sites, and followed by the *vrrA* transcription terminator ([Figure 2](#F2){ref-type="fig"}B). These vectors facilitate the parallel cloning of the sRNA of interest and aptamer-tagging at either the 5′- or 3′-end. The cloned sRNA will then be transcribed from the constitutive P~LlacO-1~ promotor; alternatively, an *Xho*I site further upstream in the plasmid facilitates the insertion of the sRNA gene with its native promoter. Cloning strategies for the individual constructs are summarized in the 'Materials and Methods' and [Supplementary Methods](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1) sections.

Aptamer-tagged sRNAs are stably expressed and functional *in vivo*
------------------------------------------------------------------

To test if and how the aptamers impacted on sRNA stability and function *in vivo*, *Salmonella* carrying sRNA expression plasmids were grown in standard media to early stationary phase, and steady-state levels of the aptamer-tagged versus wild-type sRNAs, both expressed from plasmid in the corresponding sRNA deletion strain, were compared on northern blots. In parallel, target regulation was monitored by western blot detection of OmpD (InvR), OppA (GcvB) or the major porins (RybB). The results of these analyses are shown in [Figure 3](#F3){ref-type="fig"}.

Aptamer-tagged GcvB sRNAs ([Figure 3](#F3){ref-type="fig"}A, lanes 3--8) were found to be expressed at levels comparable to wild-type GcvB (lane 2); in all cases the most prominent GcvB-derived RNA species corresponded with the expected increase in RNA length upon aptamer-tagging. Additional prominent higher molecular weight RNA species were observed with four of the GcvB constructs that are supposed to terminate with the *vrrA* terminator (lanes 4, 6--8); these are likely to result from transcripts terminating at another terminator (*rrnB*) located ∼50 bp downstream on the plasmid. The smaller bands observed for the MS2\* and 4xboxB variants (lanes 4 and 8) may indicate aberrant RNA processing events or premature termination. Except for MS2\* (lane 4) all RNAs reduced OppA protein levels to the same degree as wild-type GcvB, which suggests that aptamer tagging did not impair the regulatory properties of these sRNAs. However, even the MS2\* variant facilitated partial OppA repression.

In contrast to GcvB, aptamer-tagging strongly impacted on the steady-state level of InvR RNA ([Figure 3](#F3){ref-type="fig"}B); in fact, only two (lanes 3 and 7) out of seven tagged InvR RNAs accumulated as a single species and at levels comparable to wild-type InvR expressed from plasmid. Interestingly, in both constructs (MS2 and 1xboxB-a) transcription terminates at the native *invR* terminator whereas all but one (eIF4A-a; lane 5) of the less abundant RNAs are supposed to terminate with the *vrrA* sequence. Strikingly, in spite of varying RNA levels and prominent RNA processing all but two variants (MS2\* RNA; lane 4 and eIF4A-b RNA; lane 6) down-regulated OmpD protein synthesis comparably to wild-type InvR.

We constructed five aptamer versions of RybB RNA ([Figure 3](#F3){ref-type="fig"}C). Whilst three (MS2, 1xboxB and 4xboxB; lanes 3, 6 and 7, respectively) accumulated at or close to wild-type levels, the MS2\* (lane 4) and eIF4A (lane 5) RNAs were unstable. In contrast to GcvB and InvR, however, almost all RybB variants accumulated as a single RNA species of the predicted size. Regarding target (major porin) repression, there was good but not strictly linear correlation between steady-state levels of the regulatory RNA and the degree of repression. That is both the highly expressed MS2 and 1xboxB alleles decreased OmpA/C/D/F protein levels to the same degree as wild-type RybB (compare lanes 2, 3 and 6), whereas the poorly expressed MS2\* RNA (lane 4) largely failed to deplete the major porins. The eIF4A and 4xboxB RNA (lanes 5 and 7) both facilitated the same degree of intermediate porin expression, although 4xboxB RNA was considerably more abundant than eIF4A RNA.

When the same type of aptamer was used, the most drastic difference in terms of RNA abundance and regulation was observed with the MS2 and MS2\* RNAs (lanes 3 and 4). The aptamer position is similar in these two RNAs (fusion to residue +31 or +37, respectively, of RybB; [Figure 3](#F3){ref-type="fig"} and [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)). However, whereas the MS2 aptamer was merely inserted, i.e. without deleting any RybB nucleotides, the MS2\* aptamer was cloned such that it replaced the 3′-end of RybB. The similarly composed MS2\* versions of GcvB and InvR were also strongly impaired in target regulation. Thus, the plasmid-borne cassette of MS2\* and *vrrA* terminator may not consistently yield stable regulators, at least in *Salmonella*.

Taken together, these *in vivo* experiments suggest that the successful tagging of bacterial sRNA regulators with aptamer sequences requires empirical testing of both the tagging strategy and the insertion site in the sRNA. For the experiments to follow, we selected MS2-tagged sRNAs constructed according to cloning strategy I ([Figure 2](#F2){ref-type="fig"}A) because these yielded the most homogenous transcripts, and efficient target regulation ([Figure 3](#F3){ref-type="fig"}).

Affinity purification of *in vivo* expressed sRNAs
--------------------------------------------------

In order to test whether inserted aptamer sequences enable the purification of *in vivo* expressed sRNAs, we adapted a previously established protocol for the isolation of *in vitro* assembled spliceosomal RNPs ([@B53]) which employs MS2-MBP. [Figure 4](#F4){ref-type="fig"} gives an overview of the experimental steps. *Salmonella* expressing MS2-tagged sRNAs from plasmids are collected by centrifugation, followed by rapid lysis. A cleared lysate is then directly applied to an amylose column that is non-covalently coupled with MS2-MBP protein (via amylose binding of the MBP moiety). Upon binding of the MS2-tagged RNA species to MS2-MBP, the column is extensively washed to remove non-specifically bound RNA. Finally, the tagged sRNA and with it the associated protein(s) are eluted with a maltose-containing buffer that disrupts the MBP--amylose interaction.

All experiments described below were carried out in *Salmonella* strains in which the chromosomal copy of the sRNA of interest was deleted. We used plasmids expressing the 247 nt GcvB-MS2, the 130 nt InvR-MS2, or the 122 nt RybB-MS2 sRNAs ([Figure 3](#F3){ref-type="fig"} and [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)). Parallel experiments with plasmids expressing the cognate wild-type sRNAs were used to determine the degree of unspecific column binding.

Comparative northern blot analysis of the eluted fractions ([Figure 5](#F5){ref-type="fig"}A, lane 5) showed that the MS2 tag permitted the specific isolation of a tagged sRNA as compared to the cognate wild-type sRNA. Quantification of the northern blot signals in the lysate (input) and eluted fractions suggested that 9% of InvR-MS2 RNA was recovered. In contrast, only 0.14% of wild-type InvR RNA (which is expressed from the plasmid at the same level; [Figure 3](#F3){ref-type="fig"}B) was recovered, arguing that InvR-MS2 RNA was enriched 65-fold as compared to wild-type InvR. Of the other two MS2-tagged sRNAs, GcvB and RybB, 3.5 and 22%, respectively, were recovered from the original lysate. Based on comparison to the eluted fractions of the wild-type sRNA samples, this suggested 55-fold (GcvB) or 135-fold (RybB) enrichment. Regardless of the enrichment, we note a considerable loss of RNA already in the lysate samples; this may be caused by rapid RNA degradation in the course of cell disruption. In addition, although the bait protein was in molar excess over expressed RNAs (see quantification below), comparison of the flow-through fractions of the tagged versus untagged RNAs showed that generally \<20% of the MS2-tagged sRNAs bound to the column.

To address in a more quantitative manner which amounts of the MS2-tagged RNAs were recovered by the above affinity purifications, sRNA-specific northern blot signals of eluted RNA fractions were compared to the signal obtained with known quantities of *in vitro* transcribed sRNA ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)). From a starting material of 5 × 10^10^ (*A*~600~ of 50) bacteria, 0.35 pmol (∼25 ng) of GcvB-MS2, 2.5 pmol (∼100 ng) of InvR-MS2, and 2.1 pmol (∼80 ng) of RybB-MS2 were purified. Thus, the MS2-tagged sRNAs were recovered in quantities that should permit downstream biochemical analysis.

Co-purification of Hfq protein
------------------------------

InvR, GcvB and RybB belong to a class of bacterial sRNAs that strictly depend on the Sm-like protein, Hfq, for both intracellular stability and target regulation ([@B35],[@B36],[@B54]). All three sRNAs are enriched by co-immunoprecipitation (coIP) of Hfq in *Salmonella* lysates ([@B30],[@B32]), suggesting that they form stable complexes with Hfq *in vivo*. Therefore, if the MS2-MBP affinity approach indeed recovered sRNAs in their native form, Hfq protein should not only be detectable in the eluted fraction, but also considerably enriched with the MS2-tagged sRNAs as compared to untagged wild-type sRNAs.

We expressed the sRNAs in a *Salmonella hfq*^3×FLAG^ strain which provided a means to detect Hfq protein on western blots by way of the added FLAG epitope ([@B30]). [Figure 5](#F5){ref-type="fig"}B shows that Hfq was recovered with all three MS2-tagged sRNAs, whereas little (InvR) or no (GcvB, RybB) Hfq was detected in the elute fraction of the untagged counterparts of these sRNAs. This suggested that Hfq was purified along with the RNA, rather than by unspecific interaction with the column-bound MS2-MBP protein.

Next, Hfq^3×FLAG^ protein was over-expressed in *E. coli* and purified to homogeneity. Dilution series of the purified protein were then probed along with the protein samples from the elute fractions of MS2-tagged sRNAs, in order to determine the number of Hfq molecules that were co-purified with these sRNAs ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)). We determined 1.0, 2.6 or 1.1 pmol Hfq (monomer) in the elute fractions of GcvB-MS2, InvR-MS2, or RybB-MS2, respectively. Our successful affinity purification of Hfq protein along with MS2-tagged RNAs ([Figure 5](#F5){ref-type="fig"}) was in agreement with earlier results for the GcvB, InvR and RybB wild-type sRNAs showing (i) their enrichment by Hfq coIP ([@B30],[@B31],[@B55]) and (ii) their lower nanomolar binding affinities for purified Hfq *in vitro* ([@B35; @B36; @B37]). However, none of this excluded the possibility that Hfq primarily associated with the MS2 moiety rather than the sRNA sequence. To address this, we expressed in *Salmonella* a short RNA comprised of the MS2 tag followed by the RNA sequence of the *rrnB* transcription terminator (plasmid pRR-05). This ∼80 nt MS2 RNA was stable *in vivo*, and could be recovered by MS2-MBP affinity purification in amounts comparable with the MS2-tagged sRNAs ([Figure 5](#F5){ref-type="fig"}). Western blot analysis of the elute fraction determined 0.1 pmol Hfq. Given this weak association of Hfq with MS2 alone, the significantly higher recovery of Hfq with MS2-tagged sRNAs argues that the latter were purified as an Hfq-containing RNP that specifically assembled on the tagged sRNAs.

Optimized affinity purification
-------------------------------

The successful co-purification of Hfq with MS2-tagged InvR sRNA was taken as a departure point to improve the initial protocol. Specifically, we asked whether the incubation time with MS2-MBP fusion protein influences the recovery of tagged sRNA from the cell lysate. Cell extracts containing MS2-tagged InvR or native InvR were subjected to affinity chromatography either without any preincubation with the protein or after 20, 50 or 70 min, respectively ([Supplementary Figure S4A](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)). The results indicate that specific and efficient binding occurs immediately and preincubation is not necessary. Therefore, the cell lysate can be loaded directly on the prepared MS2-MBP/amylose resin to decrease the possibility of RNA degradation and RNP complex dissociation.

We further asked which parameters can be changed to increase the isolation yield of sRNA associated proteins. To test the influence of the quantity of bait protein, columns were loaded with 10, 50, 100 and 200 pmol MS2-MBP protein. [Supplementary Figure S4B](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1) shows that increasing MS2-MBP amounts do increase the yield of Hfq^3×FLAG^ co-purified with InvR-MS2 RNA, yet that 10 pmol of MS2-MBP suffice for efficient co-purification, at least for this sRNA. Note that high amounts of MS2-MBP protein seem to increase unspecific binding, i.e. Hfq^3×FLAG^ protein becomes detectable in the elute fraction of wild-type InvR RNA loaded onto a column with 200 pmol MS2-MBP protein ([Supplementary Figure S4B](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)).

Salt concentration can have a profound positive effect on RNA folding and the stability of non-covalent RNA--protein interactions during the course of purification ([@B56; @B57; @B58]). We tested the effects of KCl by increasing its concentration in all buffers from 150 mM to 1 M. [Figure 6](#F6){ref-type="fig"} shows that 1 M KCl permitted better co-purification of Hfq^3×FLAG^ with InvR-MS2 RNA and revealed that the increase in salt concentration did not necessarily increase background protein levels. Interestingly, the silver-stained gels also revealed that the elute fraction equivalent to 5×10^10^ *Salmonella* cells (or 25 ml of a stationary phase bacterial culture) were sufficient to visualize the Hfq^3×FLAG^ protein that co-purified with InvR-MS2 RNA. The amount of associated proteins was sufficient to perform a first proteome analysis by liquid chromatography tandem mass spectrometry (LC-MS/MS) of the tagged (InvR-MS2) RNP complexes. [Table S4](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1) summarizes the proteins that were identified. Hfq could exclusively be detected in the MS2 tagged sample but not in the non-tagged control.

MS2-tagging of a chromosomal sRNA gene
--------------------------------------

Additionally to the aptamer-tagging of sRNAs on plasmids, we have developed a strategy for MS2-tagging of chromosomal loci in order to purify sRNAs without any over-expression. To integrate the aptamer tag into the sRNA gene, we adapted a gene replacement strategy based on the one-step inactivation of chromosomal genes ([@B40]). Using a two-step PCR approach, a DNA fragment is generated that contains the aptamer-tagged sRNA and an antibiotic resistance gene, and which is then used to replace the wild-type sRNA gene by λRed-mediated recombination ([Figure 7](#F7){ref-type="fig"}A). The *rybB* gene is directly activated by the envelope stress sigma factor, σ^E^ ([@B37]). We determined that within 10 min following σ^E^ induction, MS2-tagged RybB accumulated to comparable RNA levels as RybB of a wild-type strain ([Figure 7](#F7){ref-type="fig"}B), and that the tagged RNA down-regulated the well-established *ompN* mRNA target ([@B37],[@B51]) with the same kinetics as wild-type RybB ([Figure 7](#F7){ref-type="fig"}B), arguing that the MS2 tag did not compromise RybB's activity as an *ompN* repressor.

For RNA affinity purification ([Figure 7](#F7){ref-type="fig"}C), samples were withdrawn 5 min after σ^E^ induction. As before, we could recover the MS2-tagged RybB sRNA along with Hfq protein. Specifically, we obtained ∼1.2 pmol (∼50 ng) MS2-tagged RybB and ∼7 pmol (∼100 ng) Hfq from a lysate of 200 OD~600~ of bacterial culture. This indicates that, on average, each purified RybB-MS2 molecule was associated with one Hfq hexamer, which is in perfect agreement with the stochiometry of a RybB/Hfq complex formed *in vitro* ([@B37]).

DISCUSSION
==========

There have been several studies to identify sRNA-binding proteins by way of affinity purification from lysates of *E. coli* cells. Wassarman and Storz ([@B59]) used a DNA antisense oligonucleotide directed against an extended loop region of the otherwise highly structured 6S RNA, which led to the discovery of the tight association of 6S RNA with RNA polymerase (RNAP). The Schroeder laboratory have extensively used *in vitro*-transcribed variants of *E. coli* sRNAs which carried a streptomycin aptamer tag in order to purify proteins that would bind to these sRNA upon incubation with *E. coli* lysates ([@B9],[@B60]). Mass spectrometry analysis of the purified protein fractions confirmed many predicted sRNA--protein interactions, e.g. 6S RNA/RNAP, CsrB/CsrA or OxyS/Hfq, and also revealed unexpected interactions of several sRNAs with RNAP or ribosomal S1 protein ([@B60]). In a further study, *in vitro*-transcribed ∼70 nt Rcd RNA of plasmid ColE1 was cross-linked to CNBr-activated sepharose, followed by incubation with *E. coli* lysates; step-wise elution of the retained proteins identified the enzyme, tryptophanases, as a novel target of this small RNA regulator ([@B61]).

The present study aimed at establishing whether bacterial sRNAs can be successfully modified by the addition of aptamer sequences such that they would (i) retain regulatory properties *in vivo*, and (ii) be recovered as an *in vivo* assembled RNP with their natural binding partner, Hfq, via RNA-based affinity purification. The results obtained with three model sRNAs of *Salmonella* suggest that successful tagging in terms of maintaining a homogenous RNA population will require empirical testing of several aptamers and insertion points, and that of the aptamer sequences tested here, the MS2 tag is likely to work best.

The *in vivo* expression of the aptamer-tagged sRNAs may offer advantages in comparison to solely *in vitro*-based methods. First, the functionality of the tagged sRNA can be tested by first scoring its native regulatory function *in vivo*. That is the integration of relatively large aptamers (40--80 nt) into bacterial sRNAs that are mostly ≤150 nt in length ([@B62]) inevitably comes with the risk of intramolecular structural interference, impairing the folding of the sRNA or shielding its target interaction regions. Second, *in vivo* transcription of sRNA and its target mRNA(s) might be crucial for correct assembly of active RNPs, whereas *in vitro* transcribed RNA could be trapped in an inactive fold due to absence of auxiliary factors that act co-transcriptionally *in vivo*. Third, reversible formaldehyde cross-linking *in vivo* which is commonly used to identify RNA--protein interactions may capture very transient RNPs that promote key kinetic steps in sRNA-mediated target recognition/regulation; the cross-linking may limit the loss of weakly associated factors. Last, expression of aptamer-tagged sRNAs may not only be useful for RNP purification but may also permit visualization of spatial expression pattern of an sRNA *in vivo*. That is GFP fusion proteins to MS2 or eIF4A have been successfully used to visualize the *in vivo* distribution of mRNA or 5S rRNA, respectively, in *E. coli* ([@B49],[@B63]).

To isolate *in vivo* assembled sRNA--protein complexes, antisense oligonucleotides binding to regions that remain accessible in the wild-type RNA after complex formation has been amply used. This method has the advantage that tagging of the RNA is not required, and it has been successfully applied to, e.g. the isolation of well-established spliceosomal and telomerase complexes ([@B6],[@B7]). However, purification via affinity oligonucleotides are usually more dependent on the proper salt concentrations than an aptamer approach. In general, little is known about the structure and thus the accessible regions of bacterial sRNAs *in vivo*. Therefore, the aptamer and the oligonucleotide approach equally bear the risk of missing crucial protein interactions if the targeted region is only accessible in a subcomplex.

Purification of *in vivo* formed RNPs using aptamer-tags was not previously described in prokaryotes. Whilst our study focused on three aptamer tags for the MS2-coat protein, λN~22~ peptide, and the eukaroytic initiation factor 4A, other aptamers remain to be tested. For example, active RNase P was successfully isolated from yeast following tagging of the RNA component of RNase P with a streptavidin aptamer ([@B8]). Recently, RNA affinity in tandem (RAT) was described ([@B17]). Here, the combinational use of the aptamer sequence binding to the *Pseudomonas* phage 7 coat protein and the tobramycin aptamer allowed the purification of human 7SK RNPs.

However, there are several important issues to be considered for any sRNAs to be studied with our tagging approach in the future. In the present study, we have often relied upon overexpression of the regulator (of InvR and RybB; [Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)) to ensure sufficient and comparable expression of the various sRNAs under the growth conditions used here. It is important to stress, though, that over-expression of the tagged sRNAs may allow them to function even if they are not as active as the endogenous sRNAs, or if they comprise a mixed pool of active and non-active sRNAs. In addition, the sRNA may form complexes with mRNAs and/or proteins that would not be targeted by native expression levels; may act indirectly by titrating Hfq, thereby affecting the stability of other molecules; and might dilute a relevant protein in the pool of isolated RNPs. In this respect, our demonstration that a chromosomally encoded RybB-MS2 sRNA is fully functional as an envelope stress-induced *ompN* repressor should encourage integration of tagged sRNAs in the chromosome after initial testing on plasmids.

Homogeneity of the expressed sRNAs is another issue. In this regard, if the insertion of the aptamer yield in an sRNA that retained its natural terminator sequences ([Figures 2](#F2){ref-type="fig"}A and [3](#F3){ref-type="fig"}), the RNAs are mostly expressed as homogenous species and in levels comparable the wild-type sRNAs. However, for constructs using the plasmid-borne *vrrA* terminator we often observe aberrant processing and transcriptional read-through into the downstream located *rrnB* terminator ([Figures 2](#F2){ref-type="fig"}B and [3](#F3){ref-type="fig"}). We do not currently understand the reason for the observed heterogeneity of transcripts in those latter cases. That is, the terminator of the *Vibrio* VrrA sRNA gene was chosen because it represents a heterologous sRNA terminator expected to have little influence on sRNA function in *Salmonella*, and which had been known to produce a single-sized VrrA RNA in both *Vibrio* and *Salmonella* ([@B50]). Although most of our tagged sRNAs to terminate at *vrrA* seem to be still functional *in vivo*, at least when over-expressed ([Figure 3](#F3){ref-type="fig"}), it seems advisable to integrate the aptamer such that the original sRNA terminator is retained.

Whilst the general yield of purified RNA and protein is in the practical range for biochemical studies (see below), we note that generally \<20% of MS2-tagged sRNA present in the lysate were captured on the MS2-MBP column (compare lanes 2 and 3 in [Figure 5](#F5){ref-type="fig"}). In comparison, others have reported recovery rates between 12 and 90% when using *in vitro* transcribed streptotag-modified *E. coli* sRNAs and the respective matrix ([@B60]). However, differences in the tested sRNAs as well as the fact that sRNAs were bound to the column prior to lysate application preclude a direct comparison. Regardless, if a given sRNA is only partially retained on the column (because of shielding of the aptamer by a protein or by improper folding), we must at least consider the possibility that the purified sRNA may not fully represent the active regulatory complex.

Protein visualization and comparative quantification by standard laboratory techniques, e.g. SDS--PAGE, requires minimal concentrations of co-purified proteins. The lower detection limit for proteins using standard gel staining methods is ∼2--10 ng (silver staining) or ∼10--100 ng (Coomassie) per protein band ([@B64]). It is worthwhile to mention that we could easily detect an Hfq band upon co-purification with plasmid-expressed InvR-MS2 RNA ([Figure 6](#F6){ref-type="fig"}). Therefore, our approach should be successful to recover at least the major binding partner of a sRNA of interest. Indeed a first MS-based proteome analysis revealed proteins associated with InvR-MS2 in addition to the expected Hfq protein ([Table S4](http://nar.oxfordjournals.org/cgi/content/full/gkp719/DC1)). Further studies of the detected proteins are ongoing.
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